ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

AXSM Axsome Therapeutics Inc

74,43
0,24 (0,32%)
Zuletzt aktualisiert: 19:32:59
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,24 0,32% 74,43 19:32:59
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
75,57 74,405 76,32 74,19
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202413:00GLOBEAxsome Therapeutics Recognizes May as Mental Health..
15.4.202413:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
10.4.202413:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
01.4.202413:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
25.3.202412:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
25.3.202411:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
19.3.202412:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
05.3.202413:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
01.3.202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202413:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
23.2.202414:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20.2.202413:05EDGAR2Form 8-K - Current report
20.2.202413:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
20.2.202411:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
14.2.202421:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23.1.202413:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
08.1.202413:10EDGAR2Form 8-K - Current report
04.1.202413:11EDGAR2Form 8-K - Current report
04.1.202413:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
11.12.202313:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
07.12.202322:05EDGAR2Form 8-K - Current report
07.12.202313:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
22.11.202313:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
21.11.202313:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
06.11.202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202313:05EDGAR2Form 8-K - Current report
06.11.202313:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
06.11.202312:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
02.11.202312:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
31.10.202312:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
24.10.202313:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
11.10.202323:03EDGAR2Form 8-K - Current report
11.10.202313:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10.10.202313:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
02.10.202313:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
21.9.202313:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
16.9.202300:32EDGAR2Form 144 - Report of proposed sale of securities
16.9.202300:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202313:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
05.9.202313:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
15.8.202313:45EDGAR2Form 8-K - Current report
07.8.202323:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:02EDGAR2Form 8-K - Current report
07.8.202313:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
04.8.202322:49EDGAR2Form 8-K - Current report
12.7.202313:00GLOBEAxsome Therapeutics to Report Second Quarter 2023 Financial..
07.7.202322:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07.7.202314:21EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock